P355: FAVORABLE OUTCOME OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMATINIB, DOSE-REDUCED INDUCTION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION –RESULTS FROM THE GMALL TRIAL 08/13

Ítems similars

• Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia
  per: Benjamin Kobitzsch, et al.
  Publicat: (2017-10-01)
• P355: FAVORABLE OUTCOME OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMATINIB, DOSE-REDUCED INDUCTION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION –RESULTS FROM THE GMALL TRIAL 08/13
  per: Heike Pfeifer, et al.
  Publicat: (2023-08-01)
• Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia
  per: Thomas Burmeister, et al.
  Publicat: (2007-12-01)
• Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group
  per: Thomas Burmeister, et al.
  Publicat: (2014-02-01)
• Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio
  per: Ilaria Iacobucci, et al.
  Publicat: (2007-03-01)